Immunodeficiency Information
Health Professional Information
- Primary Immunodeficiencies (PID) e-training for health professionals
- Immunoglobulin Replacement Therapy (IRT) e-training for health professionals New March 2022
- Hereditary Angioedema (HAE) e-training for health professionals In development
- ASCIA Immunodeficiency Strategy for Australia and New Zealand
- Immunodeficiency Overview
- ASCIA Position Statement - COVID-19 Prophylaxis in People with Immune Deficiencies New May 2022
- ASCIA Position Statement - Immunoglobulin Replacement Therapy (IRT) in Primary Immunodeficiency (PID) New September 2021
- ASCIA Webinar - HAE
- ASCIA Position Paper and Management Plan - Hereditary Angioedema (HAE)
- ASCIA Clinical Update - Primary Immunodeficiencies (PID)
- ASCIA Position Statement - Subcutaneous Immunoglobulin (SCIg)
- ASCIA Guide – Setting up a Subcutaneous Immunoglobulin (SCIg) program in a hospital
- ASCIA Guidelines for Diagnosis and Management of Severe Combined Immunodeficiency (SCID) in Australia and New Zealand: A TAPID Consensus Guideline
- ASCIA Guidelines - Standardised IVIg Infusion Rates for IRT
- ASCIA SCIg Treatment Plan
- ASCIA Transfer Care Plan for patients on IRT (immunoglobulin replacement therapy)
- ASCIA Travel Plan for patients on SCIg (subcutaneous immunoglobulin) therapy
- ASCIA SCIg Competency Training Checklists New May 2022
- ASCIA ID Register How to access information (available to Members Only)
- References - Immunodeficiency
- References - Hereditary Angioedema (HAE)
Page created June 2022